Ludwig, Heinz http://orcid.org/0000-0002-3302-8726
Funding for this research was provided by:
Austrian Forum against Cancer
Article History
Received: 14 July 2021
Revised: 2 September 2021
Accepted: 7 September 2021
First Online: 17 September 2021
Competing interests
: HL: research funding: Amgen, Takeda; Speaker’s Honoraria and Advisory Boards: Amgen, Takeda, Sanofi, Janssen, Celgene-BMS, Seattle Genetics.